🇺🇸 Cliquinol in United States

Cliquinol (CLIOQUINOL) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA050235
  • Marketing authorisation holder: BAYER PHARMS
  • Local brand name: NYSTAFORM
  • Indication: OINTMENT — TOPICAL
  • Status: approved

Read official source →

Cliquinol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Cliquinol approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for Cliquinol in United States?

Marketing authorisation holder not available in our data.